Tilray (TLRY) plans to announce its third-quarter earnings results before the market opens on Tuesday, April 9.
The consensus estimate for earnings per share is -0.05 USD (a decrease of 25.0% year-on-year), with a revenue consensus estimate of 1.9833 billion USD (an increase of 36.2% year-on-year).
Over the past two years, TLRY has exceeded earnings per share expectations 50% of the time and revenue expectations 13% of the time.
In the past 3 months, there has been 1 upward revision and 1 downward revision in earnings per share expectations. Revenue forecasts have seen 1 upward revision and 9 downward revisions.
&#34;Analysts have lowered their forecasts for Tilray's future revenue and adjusted EBITDA, and the stock's performance remains challenging,&#34; wrote investment group leader and CFA Alan Brochstein in his analysis &#34;Tilray May Collapse&#34;.
Both Wall Street analysts and Seeking Alpha's quantitative rating system rate the stock as a buy, while Seeking Alpha analysts recommend selling.
The stock has seen a significant increase in recent weeks, nearly doubling in price over the past two weeks:
<img src="https://pub.pbkrs.com/cms/2024/0/e3AxfCfTXQhqsidQj9FAP3PhxExrcQ1F.jpg?x-oss-process=style/lg" alt="" original-src="https://pub.pbkrs.com/cms/2024/0/e3AxfCfTXQhqsidQj9FAP3PhxExrcQ1F.jpg"/>
Peers in the industry such as Aurora Cannabis (ACB) and Sundial Growers (SNDL) have also seen impressive gains.
Historically, industrial cannabis stocks have experienced maximum declines of over 95%

TLRY

SNDL

The stock has seen a significant increase recently, almost doubling in price in just over half a month. Other industry peers such as Aurora Cannabis (ACB) and Sundial Growers (SNDL) have also experienced impressive gains

Performance Outlook | Industrial Cannabis Stock Tilray, Stock Price Expected to Double in the Short Term